Supernumerary lacrimal puncta: case series and review of the literature
Omar Mahmoud Solyman, Hashem Abdulaziz Abu Serhan, Mohammad Ali Tahboub, Mokhtar Mohamed Ibrahim Abushanab, Hesham Ali Hashem, Amr Mohammed Aref, Ahmed Sobh Abo Obaia, Hesham Foad Kamel
Corresponding author: Omar Mahmoud Solyman, Department of Ophthalmology, Research Institute of Ophthalmology, Giza, Egypt
Received: 13 Sep 2022 - Accepted: 10 Jul 2023 - Published: 24 Jul 2023
Domain: Ophthalmology
Keywords: Supernumerary puncta, double lacrimal puncta, punctum duplication, accessory punctum, lacrimal drainage system, dry eye, epiphora
©Omar Mahmoud Solyman et al. Pan African Medical Journal (ISSN: 1937-8688). This is an Open Access article distributed under the terms of the Creative Commons Attribution International 4.0 License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Cite this article: Omar Mahmoud Solyman et al. Supernumerary lacrimal puncta: case series and review of the literature. Pan African Medical Journal. 2023;45:140. [doi: 10.11604/pamj.2023.45.140.37326]
Available online at: https://www.panafrican-med-journal.com//content/article/45/140/full
Supernumerary lacrimal puncta: case series and review of the literature
Omar Mahmoud Solyman1,2,&, Hashem Abdulaziz Abu Serhan3, Mohammad Ali Tahboub4, Mokhtar Mohamed Ibrahim Abushanab1, Hesham Ali Hashem1, Amr Mohammed Aref1, Ahmed Sobh Abo Obaia1, Hesham Foad Kamel1
&Corresponding author
We report a case series of supernumerary puncta-canaliculi, a very rare congenital anomaly, and describe different clinical presentations and new treatment options. This is a retrospective chart review of patients diagnosed with supernumerary lacrimal puncta during the time between June 2015 and December 2021 at the Research Institute of Ophthalmology, Giza, Egypt. Four patients (two females and two males) with a mean presenting age of 54 ± 14 years had unilateral double puncta. Of those four patients, three had double puncta on the right lower eyelid whereas one had double puncta on the left upper and lower eyelid. In one of the three patients, the double puncta anomaly was an incidental finding, and the patient was asymptomatic. The other three patients had associated epiphora. All four patients were found to have patent double puncta with no mechanical obstruction. No surgical interventions were necessary for all four patients as one resolved after discontinuing the topical eye drops. Another patient resolved after the diagnostic probing of the puncta, and the third asymptomatic patient required no interventions. Epiphora in the fourth patient resolved with botulinum toxin injection in the lacrimal gland. Accessory lacrimal puncta can present in patients as an incidental asymptomatic finding or patients may present with epiphora. Patients who present with unilateral epiphora, dry eye, or canaliculitis should be carefully evaluated with a detailed slit-lamp examination using lid eversion to appreciate potentially easily missed supernumerary lacrimal puncta.
Supernumerary puncta are rare congenital defects of the lacrimal drainage system. The incidence is not completely known. As cited in Chignell et al. a Wicherkiewicz report stated that it may be seen in 1 in 60000 eyes [1]; another report by Bacskulin et al. stated that it may be more common than previously thought, with an incidence of 1 in 800-1000 eye cases [2]. The underlying mechanism for this anomaly is still undetermined, however, it has been suggested that there may be an irregularity during embryological development [1,3,4]. It may begin with an irregular budding of the ectodermal core, which invades the mesoderm of the lid and becomes what is known as the lacrimal puncta-canaliculi [1]. Double lacrimal puncta are mostly asymptomatic, however, epiphora, dry eyes, and canaliculitis have been reported to be associated with these anomalies [1,3,5-14]. These findings can be easily missed during a routine ocular examination; thus, careful slit lamp examination is highly recommended to detect these anomalies. In this case series, we report four different patients with accessory lacrimal puncta with different clinical presentations. Along with our case series, multiple other case series and reports were compiled in this paper to demonstrate the presence of supernumerary puncta in the literature; the goal is to compare and highlight the treatments and interventions that may be of benefit to symptomatic supernumerary puncta patients.
This is a case series report, a descriptive study based on a retrospective chart review of patients diagnosed with supernumerary lacrimal puncta during the time between June 2015 and December 2021 at the Research Institute of Ophthalmology, Giza, Egypt. All patients diagnosed with supernumerary lacrimal puncta were included. Consent was waived and publication was approved by the research ethics committee of the Research Institute of Ophthalmology.
Four patients (two females and two males) with a mean presenting age of 54 ± 14 years had unilateral double puncta. Of those four patients, three had double puncta on the right lower eyelid whereas one had double puncta on the left upper and lower eyelid. In one of the four patients, the double puncta anomaly was an incidental finding, and the patient was asymptomatic. The other three patients had associated epiphora. All four patients were found to have patent double puncta with no mechanical obstruction. No surgical interventions were necessary for all four patients as one resolved after discontinuing the topical eye drops. Another patient resolved after the diagnostic probing of the puncta, and the third asymptomatic patient required no interventions. Epiphora in the fourth patient resolved with botulinum toxin injection in the lacrimal gland.
Case-1: a 66-year-old female presented to the clinic with left eye tearing for two weeks. The patient had not undergone any ocular surgery except cataract surgery in the left eye 3 weeks prior to the presentation. The best corrected visual acuity (BCVA) was 20/20 right eye (OD) and left eye (OS). Intraocular pressure (IOP) was 13 mmHg OD and 14 mmHg OS. Slit lamp examination disclosed the presence of unilateral double punctum in both the left upper and lower eyelids (Figure 1 A, B) along with increased fluorescein disappearance time in the left eye. Lacrimal drainage system irrigation demonstrated that each punctum was patent on both the left upper and lower eyelids. Simultaneous probing of each of the two puncta on both eyelids revealed an initial separate canaliculus for each punctum that joined to make a conjoint canaliculus about 5-6 mm in both eyelids. The excessive tearing was felt to be secondary to partial canalicular obstruction from the prolonged use of the postoperative topical antibiotic and corticosteroid eye drops post-cataract surgery. The patient was advised to discontinue the eye drops. She reported gradual improvement of tearing to complete resolution in about one month.
Case-2: a 39-year-old female with no known prior medical or ocular history or surgeries was referred to the oculoplastic service for evaluation of the right epiphora. The epiphora started gradually over the year prior to the presentation. The best corrected visual acuity was 20/20 OD and 20/25 OS. Intraocular pressure was 15 mmHg OD and OS. Slit lamp examination was remarkable for double puncta in the right lower eyelid (Figure 1 C) along with a prolonged fluorescein dye disappearance test on the right side compared to the left side. Probing of the right lower eyelid showed patent puncta and canaliculi with no evidence of conjoint canaliculus for the double puncta on simultaneous probing. Irrigation of the lower punctum showed a patent nasolacrimal duct with partial regurgitation from the medial accessory punctum. The epiphora was likely a result of an incompetent lacrimal pump mechanism, however, the cause of the late presentation of the symptomatology could not be explained. The patient was consulted and offered interventions to relieve her symptoms including surgical occlusion of the medial accessory punctum to improve the lacrimal pump mechanism. The patient reported a subjective improvement of her right epiphora after the diagnostic probing and turned down other interventions.
Case-3: a 46-year-old male presented to the general eye clinic for evaluation of a stye on the lower eyelid of the right eye. He had a past ocular history of vernal keratoconjunctivitis as a child. The best corrected visual acuity was 20/25 OD and OS. Intraocular pressure was 16 mmHg OD and 19 mmHg OS. Slit lamp examination revealed double puncta on the right lower eyelid (Figure 1 D). He was unaware of this anomaly and denied any other ocular symptoms including excessive tearing or dry eye. The patient´s dye disappearance test and Schirmer test were within normal limits for both eyes. No further workup was performed for this patient after the incidental finding was noted.
Case-4: a 67-year-old male patient with chronic sinusitis and an ocular history of essential blepharospasm for several years who newly established clinical care with our service complained also of tearing from the right eye for a few years. The patient reported that in summer, his right eye is usually full of tears that occasionally impair his vision and require dapping during his outdoor activity. During other months of the year, his vision is more frequently impaired with the tears that also overflow on his cheek and require more frequent dapping. Examination showed double lacrimal puncta in the right lower eyelid with a prolonged fluorescein disappearance test in the right compared to the left eye (Figure 1 E). Probing and irrigation showed patency of both puncta with regurgitation of tears from the proximal punctum. A combination of a defective lacrimal pump and partial nasolacrimal duct obstruction was felt to be the cause of epiphora in the right eye. The patient was offered different treatment options but he opted to have a botulinum toxin injection in the lacrimal gland along with facial botulinum toxin injections for essential blepharospasm every three months. Four units of botulinum toxin- A were injected transconjunctivally into the palpebral lobe of the right lacrimal gland and the patient reported improvement of epiphora despite the persistence of the prolonged tear disappearance test.
The lacrimal punctum is an opening on the strong fibrous mound of the lacrimal papilla. The puncta are 0.2-0.3 mm in diameter with the inferior punctum and the superior punctum being 6.5 mm and 6.0 mm, respectively, away from the medial canthus [15]. Each respective punctum continues into the lacrimal canaliculus which passes through an approximately 2 mm vertical portion and an 8-10 mm horizontal portion [15]. The upper and lower canaliculi often merge to form a common canaliculus in about 90% of the population, which then empties into the sinus of Maier and through the one-way valve of Rosenmuller into the lacrimal sac [15]. The canaliculi have a mucosa that is composed of non-keratinized stratified squamous epithelium while the lacrimal sac is lined by pseudostratified epithelium [16]. And finally, the lacrimal fluid drains inferiorly from the lacrimal sac into the nasal cavity through the 12-18 mm long nasolacrimal duct [17].
Accessory lacrimal puncta and canaliculi are rare congenital anomalies that are underreported in the literature. We have compiled multiple case series and reports to exhibit trends and potential standardized treatments that may be of benefit to symptomatic double puncta patients (Table 1). In the table, there were a total of 51 patients with supernumerary puncta including the four patients in our case series [1,3,5-14]. There were a total of 27 female (53%) and 24 male (47%) patients. There were 17 supernumerary puncta patients that were asymptomatic in regard to the anomaly (33%), 30 patients with epiphora (59%), 2 patients with dry eye (4%), 2 patients with canaliculitis (4%), 1 patient with conjunctivitis (2%), and 1 patient with stage IV trachoma and chronic infection (2%). The total percentage added up to more than 100% due to some patients exhibiting multiple symptoms likely due to the presence of double puncta. And according to Chignell et al. [1] it was unlikely conjunctivitis and the chronic infection in the two patients from their case series were due to the double puncta. We had three patients presenting with epiphora and one patient was asymptomatic. Bair et al. and Chignell et al. suggested that the right lower lid is the most reported location for the occurrence of supernumerary puncta [1,6]. Thirty-nine patients out of the total 51 patients (76%) were found to have had right lower lid supernumerary puncta which is consistent with previous reports [1,3,5-14].
Similarly, cases 2, 3, and 4 of our case series had the right lower eyelid affected. Our first case, however, had the left upper and lower eyelids affected. The supernumerary puncta most commonly occurs in doubles, however, the most recorded puncta number on an eyelid was four [2,18]. Our case series of four patients showed similar trends, with all four having only double puncta on any one eyelid. It was also consistent with the comprehensive table results which demonstrated the vast majority of patients presenting with double puncta on any one eyelid (98%) and only one patient out of the 51 (2%) with triple puncta in an eyelid that only had intermittent epiphora and no interventions performed [1,3,5-14]. Forty-six percent of patients (n=23) in the table were reported by Satchi et al. which is the largest case series to date of patients with supernumerary puncta [5]. In their series, the presence of double puncta was an incidental finding in only five patients, whereas the other 18 patients presented with unilateral epiphora on the same side as the double puncta [5].
Although accessory lacrimal puncta can be asymptomatic, a variety of symptoms have been attributed to the presence of double puncta including but not limited to dry eyes, epiphora, and canaliculitis [1,3,5-14] In this discussion, we will describe each of the three associated symptoms and their potential causes.
Dry eyes can be the sole manifestation of supernumerary puncta canaliculi. Several theories have been proposed including enhanced outflow of the supernumerary system leading to increased tear excretion in the affected eye, resulting in accelerated dryness [5,6]. Another theory was that the anatomical relationship between the site of origin of the accessory canaliculus and Horner´s muscle can determine the direction of tear flow within the accessory puncta and canaliculus, which can be the cause of both dry eye and epiphora [5]. Several case reports have described the insertion of punctal plugs as a successful intervention for dry eyes in the context of supernumerary puncta [6,7]. In addition to punctal plugs, thermal cautery had been described as an alternative line of management in cases of double puncta canaliculi [6].
Congenital supernumerary puncta can present as excessive unilateral tearing [3,5]. There are a few mechanisms that are suggested in the literature that may explain this presentation in many patients. One possible explanation for the excessive tearing is a reduced lacrimal pump function [3]. The lacrimal pump is important for drawing tears into the lacrimal sac through the contraction of Horner´s muscle. However, the presence of double puncta can affect the lacrimal pump´s mechanism which may result in excessive tearing [3]. Another possible explanation for the occurrence of epiphora in patients with a patent nasolacrimal duct is the reflux of tears through the accessory punctum; tears may flow back towards the path of least resistance, and in this case, it is likely back to the tear film rather than the nasolacrimal duct [3]. Nasolacrimal duct obstruction is a common condition seen in patients who have double puncta, and it is also a potential cause of epiphora presentation [5]. In fact, Satchi et al. found that 5 out of 18 patients who had symptoms of epiphora from their double puncta had complete nasolacrimal duct obstruction, while the remaining 13 patients had either partial nasolacrimal duct obstruction or functional epiphora [5].
The embryological development of the lacrimal drainage apparatus may play a significant role in these patients with epiphora along with supernumerary puncta and nasolacrimal obstruction. The lacrimal drainage system develops at 5-10 weeks gestational age, beginning with lacrimal sac development followed by simultaneous co-formation of the canaliculi and nasolacrimal duct from invaginated ectoderm [3,4]. This simultaneous co-development could signify that a developmental or environmental injury to the embryological ectoderm at this critical point in development can lead to a concurrent abnormality in the nasolacrimal duct development, thus, increasing its resistance to tearing flow and predisposing it to obstruction [3,4]. Another report described the development of congenital supernumerary puncta occurring due to irregular budding of the ectodermal core, which invades the mesoderm of the lid and becomes what is known as the lacrimal puncta-canaliculi [1]. An abnormality arising during development may explain the symptomatic epiphora presentation for a supernumerary puncta anomaly patient.
Lines of epiphora management and treatment ranged from no surgical interventions to dacryocystorhinostomy (DCR) or punctoplasty, reflecting the secondary possible mechanisms for each patient [1,3,5-14] Various case series have reported successful DCR procedures, including the largest report by Satchi et al. in which 11 out of 12 patients reported resolution or improved symptoms postoperatively [1]. Timlin et al. had a smaller sample size of DCR patients (n=2) but demonstrated similar success. They used a Munk scoring system to describe the before and after DCR severity of epiphora symptoms; the scores ranged from 0-4 where ´0´ corresponds to no epiphora and a score of ´4´ corresponds to epiphora requiring dabbing more than 10 times a day [3]. The Munk scores for both patients 4-8 weeks postoperatively went from ´4´ to ´1´ and ‘0´. In the same report, one patient underwent punctoplasty and reduced his epiphora from a Munk score of ´4´ to ´2´ eight weeks postoperative [3]. Chun and Yang also found success in a 45-year-old female patient with bilateral upper and lower double puncta and symptomatic epiphora; they performed bilateral DCR and found the patient to be symptom-free postoperatively [12]. Ucar and Karadag performed DCR on another epiphora double puncta patient and demonstrated a resolution of symptoms in the one-month follow-up postoperatively [13]. The improvement and resolution of symptoms in many of these patients suggest that DCR and punctoplasty may be reasonable interventions for symptomatic epiphora.
Case-4 in this series responded well to botulinum toxin-A injection into the palpebral lobe of the right lacrimal gland. Botulinum toxin injection into either the palpebral or the main lacrimal gland lobes has been described as a less invasive treatment option for patients with epiphora with canalicular obstruction [19,20]. This patient had essential blepharospasm for which he receives botulinum toxin injection 3-4 times a year. He was injected with 4 units of botulinum toxin in the palpebral lobe of the right lacrimal gland during a scheduled injection session for essential blepharospasm with the resolution of epiphora over 2-months of follow-up. To the best of our knowledge, this is the first description of botulinum toxin injection in the treatment of multiple lacrimal puncta-associated epiphoras. Although we had no cases of canaliculitis associated with the double punctum anomaly, it is important to discuss their association. Yong et al. described the first association of a 59-year-old male with double puncta and ipsilateral canaliculitis [8]. They have proposed that an abnormal embryological development may be the reason for such an association. The patient´s inner and outer punctum may have undergone different paths during development. The inner punctum underwent complete canalization maintaining its connection with the main epithelial cord. The outer punctum separated from the main epithelial cord, creating a cul-de-sac prone to pathology. This anomalous cul-de-sac became a nidus for infection due to the sequestration of tears and debris over time [8]. The resultant canaliculitis can be treated with oral antibiotics [8]. Another report by Timlin et al. described a patient with lower left eyelid double puncta and ipsilateral upper punctum canaliculitis [3]. They performed an upper punctum canaliculotomy to treat and resolve the infection and were not able to find upper canaliculus abnormalities, thus, they were unsure of the relation between the anomaly and the infection [3].
Accessory lacrimal puncta can present in patients as an incidental asymptomatic finding or with a variety of symptoms. In our case series, we highlight four interesting cases of patients presenting either asymptomatically or with epiphora. Other case series have reported other symptoms such as canaliculitis. Patients who present with unilateral epiphora or dry eye should be carefully evaluated with a detailed slit-lamp examination using lid eversion to appreciate potentially easily missed supernumerary lacrimal puncta.
What is known about this topic
- Accessory lacrimal puncta and canaliculi are rare congenital anomalies that are underreported in the literature;
- Supernumerary puncta patients could be asymptomatic or presented with epiphora, dry eye, canaliculitis, conjunctivitis, trachoma, and chronic infection;
- The right lower lid is the most reported location for the occurrence of supernumerary puncta.
What this study adds
- Double lacrimal puncta and canaliculi may predispose to canalicular obstruction medicamentosa;
- We described possible lines of epiphora management and treatment by giving recommendations about a stepwise management approach including the first use of botulinum toxin-A injection in the lacrimal for treatment of epiphora secondary to double lacrimal puncta and canaliculi;
- We report a rare case of double lacrimal puncta and canaliculi in both eyelids of the same eye.
The authors declare no competing interests.
Omar Mahmoud Solyman, Hesham Foad Kamel, and Hashem Abdulaziz Abu Serhan conceived and designed the study, and were responsible for data collection and acquisition of data. Mohammad Ali Tahboub, Mokhtar Mohammed Abushanab, Hesham Ali Hashem, Amr Mohammed Aref, and Ahmed Sobh Abo Obaia, performed the literature review and wrote the manuscript. Omar Mahmoud Solyman, Hesham Foad Kamel, and Hashem Abdulaziz Abu Serhan reviewed and critically revised the manuscript. All authors have read and approved the final manuscript.
Table 1: summary of previous reports of supernumerary puncta
Figure 1: supernumerary puncta (blue arrows) (A, B) on slit lamp examination of patient-1 left upper and lower eyelids respectively; (C, D, E) supernumerary puncta on the lower right eyelid in patients 2, 3 and 4
- Chignell AH. Double punctum and canaliculus. Am J Ophthalmol. 1968 May;65(5):736-9. PubMed | Google Scholar
- Bacskulin J. Double, triple and quadruple lacrimal puncta. Klin Monbl Augenheilkd. 1964 Apr;144:418-28. PubMed | Google Scholar
- Timlin HM, Keane PA, Ezra DG. Characterizing Congenital Double Punctum Anomalies: Clinical, Endoscopic, and Imaging Findings. Ophthalmic Plast Reconstr Surg. 2019 Nov/Dec;35(6):549-552. PubMed | Google Scholar
- de la Cuadra-Blanco C, Peces-Peña MD, Jáñez-Escalada L, Mérida-Velasco JR. Morphogenesis of the human excretory lacrimal system. J Anat. 2006 Aug;209(2):127-35. PubMed | Google Scholar
- Satchi K, McNab AA. Double lacrimal puncta: clinical presentation and potential mechanisms of epiphora. Ophthalmology. 2010 Jan;117(1):180-183.e2. PubMed | Google Scholar
- Bair PJ, Tsai YY, Lin JM. Congenital reduplication of the lacrimal punctum and canaliculus in a patient with dry eye. Ophthalmic Surg Lasers Imaging. 2004 Mar-Apr;35(2):156-8. PubMed | Google Scholar
- Galindo-Ferreiro A, AlGhafri L, Akaishi P, Galvez-Ruiz A, Galindo-Alonso J, Schellini S et al. Punctal Plug as a Treatment Option for Dry Eye Associated with Congenital Supernumary Puncta. Middle East Afr J Ophthalmol. 2018 Jul-Dec;25(3-4):170-172. PubMed | Google Scholar
- Yong KC, Kah TA, Annuar FH. Canaliculitis in supernumerary puncta and canaliculi. Clin Pract. 2011 Jul 1;1(3):e59. PubMed | Google Scholar
- Lacroix Z, Bitton E. Supernumerary punctum: an unusual case of seeing double. Clin Exp Optom. 2015 Jul;98(4):375-8. PubMed | Google Scholar
- Afifa Azam SK, Samir Kumar Lal. Supernumerary lacrimal puncta: A case report. Indian Journal of Clinical and Experimental Ophthalmology. 2020;6(4):642-4. Google Scholar
- Osorio RF. Congenital supernumerary lacrimal puncta and canaliculus on the caruncle. J Clin Ophthal Optan. 2017;1:101.
- Chun JW, Yang SW. A Case of a Congenital Lacrimal Outflow Dysgenesis with Supernumerary Lacrimal Puncta. J Korean Ophthalmol Soc. 2013 6;54(6):958-61. Google Scholar
- Ucar IC, Karadag R. Double puncta canaliculi may exhibit different clinical presentations. Arq Bras Oftalmol. 2020 Jun;83(3):236-238. PubMed | Google Scholar
- Al Saleh A, Vargas JM, Al Saleh AS. Supernumerary lacrimal puncta: Case series. Saudi J Ophthalmol. 2021 Jul 29;34(4):328-330. PubMed | Google Scholar
- Paulsen F, Garreis F, Schicht M, Bräuer L, Ali MJ, Sel S. Anatomy and physiology of the nasolacrimal ducts. HNO. 2016 Jun;64(6):354-66. PubMed | Google Scholar
- Kominami R, Yasutaka S, Taniguchi Y, Shinohara H. Anatomy and histology of the lacrimal fluid drainage system. Okajimas Folia Anat Jpn. 2000 Dec;77(5):155-60. PubMed | Google Scholar
- Tamboli DA, Harris MA, Hogg JP, Realini T, Sivak-Callcott JA. Computed tomography dimensions of the lacrimal gland in normal Caucasian orbits. Ophthalmic Plast Reconstr Surg. 2011 Nov-Dec;27(6):453-6. PubMed | Google Scholar
- Greeves RA. Supernumerary Punctum Lachrymale and Canaliculus. Proc R Soc Med. 1914;7(Sect Ophthalmol):141-2 PubMed | Google Scholar
- Lee AG, Lee SH, Jang M, Lee SJ, Shin HJ. Transconjunctival versus Transcutaneous Injection of Botulinum Toxin into the Lacrimal Gland to Reduce Lacrimal Production: A Randomized Controlled Trial. Toxins (Basel). 2021 Jan 21;13(2):77. PubMed | Google Scholar
- Jeffers J, Lucarelli K, Akella S, Setabutr P, Wojno TH, Aakalu V. Lacrimal gland botulinum toxin injection for epiphora management. Orbit. 2022 Apr;41(2):150-161. PubMed | Google Scholar